Telix Pharmaceuticals Company Top Insiders
TLPPF Stock | USD 16.00 0.82 5.40% |
Telix Pharmaceuticals employs about 11 people. The company is managed by 11 executives with a total tenure of roughly 26 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Telix Pharmaceuticals' management performance can provide insight into the company performance.
Jyoti BappSc Insider Chief APAC |
Meredith Crowe Insider Interim Culture |
Telix |
Telix Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.4111) % which means that it has lost $0.4111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5507) %, meaning that it generated substantial loss on money invested by shareholders. Telix Pharmaceuticals' management efficiency ratios could be used to measure how well Telix Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Telix Pharmaceuticals Workforce Comparison
Telix Pharmaceuticals Limited is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 25,621. Telix Pharmaceuticals adds roughly 11.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Telix Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Telix Pharmaceuticals Price Series Summation is a cross summation of Telix Pharmaceuticals price series and its benchmark/peer.
Telix Pharmaceuticals Notable Stakeholders
A Telix Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Telix Pharmaceuticals often face trade-offs trying to please all of them. Telix Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Telix Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jyoti BappSc | Chief APAC | Profile | |
Meredith Crowe | Interim Culture | Profile | |
BSc BSc | Chief Scientist | Profile | |
Christian Davis | EMEA Marketing | Profile | |
Andreas MD | Chief Director | Profile | |
Amanda Griffin | Communications Mang | Profile | |
BEng DPhil | Group CoFounder | Profile | |
Kyahn Williamson | Sr Relations | Profile | |
BBus FCPA | Group Officer | Profile | |
Lena MoranAdams | G Counsel | Profile | |
AGIA ACG | Risk Governance | Profile |
About Telix Pharmaceuticals Management Performance
The success or failure of an entity such as Telix Pharmaceuticals often depends on how effective the management is. Telix Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Telix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Telix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation products for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company was founded in 2015 and is headquartered in North Melbourne, Australia. Telix Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Telix Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Telix Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Telix Pharmaceuticals within its industry.Telix Pharmaceuticals Manpower Efficiency
Return on Telix Pharmaceuticals Manpower
Revenue Per Employee | 445.3K | |
Revenue Per Executive | 445.3K | |
Net Loss Per Employee | 7.3M | |
Net Loss Per Executive | 7.3M |
Complementary Tools for Telix Pink Sheet analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |